Tuesday, May 24, 2016

UPDATE 1-SEC raises concerns about Valeant's use of "Non-GAAP" measures

May 24 (Reuters) - The Securities and Exchange Commission is

concerned about the way Canadian drugmaker Valeant

Pharmaceuticals International Inc has been disclosing

its "non-GAAP" financial measures, regulatory filings showed on

Tuesday.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)